• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T4期口腔癌患者对新辅助化疗的依从性:地点、个人、社会经济地位还是援助因素?

Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance.

作者信息

Patil Vijay M, Noronha Vanita, Joshi Amit, Muddu Vamshi, Dhumal Sachin, Bhattacharjee Atanu, Prabhash Kumar

机构信息

Tate Memorial Hospital, Mumbai.

Malabar Cancer Centre, Kerala, India.

出版信息

J Glob Oncol. 2015 Oct 28;1(2):65-72. doi: 10.1200/JGO.2015.000265. eCollection 2015 Dec.

DOI:10.1200/JGO.2015.000265
PMID:28804775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5539870/
Abstract

PURPOSE

Approximately 15% to 20% of our patients with head and neck cancer receiving neoadjuvant chemotherapy (NACT) discontinue therapy because of various nonmedical reasons. We sought to analyze the factors associated with treatment default and noncompliance among these patients.

PATIENTS AND METHODS

We performed a retrospective analysis of patients with T4 oral cancer treated with NACT between January 2011 and December 2012. We included patients who discontinued treatment for nonmedical reasons before the second cycle of NACT. The factors analyzed were income, education, socioeconomic status, age, sex, place of residence, habits, and payment pattern (government supported or personal capacity). Pearson χ test was used to identify significant factors associated with noncompliance.

RESULTS

Of 486 patients, 91 patients (18.7%) were noncompliant. Percentages of noncompliant patients in the age groups < 30, between 30 and 60, and > 60 years were 25.0%, 17.4%, and 25.5%, respectively ( = .27). Percentages of noncompliance in patients residing within the city, same state, or different state were 20.7%, 20.9%, and 17.1%, respectively ( = .44). Noncompliance rates were 20.3%, 15.7%, 18.1%, and 22.5% in upper middle, lower middle, upper lower, and lower economic strata, respectively ( = .60). Similarly, there was no significant difference in noncompliance according to occupation, education level, payment pattern, sex, or habits.

CONCLUSION

Our analysis failed to identify any specific significant factor associated with noncompliance with NACT among our patients with T4 oral cancers.

摘要

目的

在接受新辅助化疗(NACT)的头颈癌患者中,约15%至20%会因各种非医疗原因中断治疗。我们试图分析这些患者中与治疗违约和不依从相关的因素。

患者与方法

我们对2011年1月至2012年12月期间接受NACT治疗的T4期口腔癌患者进行了回顾性分析。纳入在NACT第二个周期之前因非医疗原因中断治疗的患者。分析的因素包括收入、教育程度、社会经济地位、年龄、性别、居住地点、习惯和支付方式(政府支持或个人支付)。采用Pearson χ检验来确定与不依从相关的显著因素。

结果

486例患者中,91例(18.7%)不依从。年龄<30岁、30至60岁和>60岁组的不依从患者百分比分别为25.0%、17.4%和25.5%(P = .27)。居住在本市、本州或其他州的患者不依从百分比分别为20.7%、20.9%和17.1%(P = .44)。社会经济阶层中上层、中层、中下层和下层的不依从率分别为20.3%、15.7%、18.1%和22.5%(P = .60)。同样,根据职业、教育水平、支付方式、性别或习惯,不依从情况也无显著差异。

结论

我们的分析未能在T4期口腔癌患者中确定任何与NACT不依从相关的特定显著因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8277/5539870/4fec61b2d2c0/jgo9991500150001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8277/5539870/4fec61b2d2c0/jgo9991500150001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8277/5539870/4fec61b2d2c0/jgo9991500150001.jpg

相似文献

1
Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance.T4期口腔癌患者对新辅助化疗的依从性:地点、个人、社会经济地位还是援助因素?
J Glob Oncol. 2015 Oct 28;1(2):65-72. doi: 10.1200/JGO.2015.000265. eCollection 2015 Dec.
2
Referral pattern for neoadjuvant chemotherapy in the head and neck cancers in a tertiary care center.三级医疗中心头颈癌新辅助化疗的转诊模式
Indian J Cancer. 2014 Apr-Jun;51(2):100-3. doi: 10.4103/0019-509X.137956.
3
Predictors of radiation therapy noncompliance in an urban academic cancer center.城市学术癌症中心放射治疗不依从性的预测因素
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):232-8. doi: 10.1016/j.ijrobp.2014.09.030.
4
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.对于局部进展非常严重、技术上无法切除的口腔癌,先进行新辅助化疗,然后再进行手术。
Oral Oncol. 2014 Oct;50(10):1000-4. doi: 10.1016/j.oraloncology.2014.07.015. Epub 2014 Aug 15.
5
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients.乳腺癌患者不遵守辅助放疗、化疗或激素治疗的情况。
Am J Surg. 2008 Oct;196(4):500-4. doi: 10.1016/j.amjsurg.2008.06.027.
6
Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? A large-scale retrospective study.新辅助化疗能否改变宫颈癌淋巴结清扫的范围?一项大规模回顾性研究。
PLoS One. 2015 Apr 10;10(4):e0123539. doi: 10.1371/journal.pone.0123539. eCollection 2015.
7
Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: does it make a difference?技术上无法切除的局部晚期口腔癌的诱导化疗:有区别吗?
Indian J Cancer. 2013 Jan-Mar;50(1):1-8. doi: 10.4103/0019-509X.112263.
8
Treatment compliance and noncompliance in psychoses.精神病治疗的依从性与不依从性
Indian J Psychiatry. 2017 Jan-Mar;59(1):69-76. doi: 10.4103/psychiatry.IndianJPsychiatry_24_17.
9
The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.新辅助化疗治疗局部晚期宫颈癌的疗效与安全性:一项随机多中心研究。
Gynecol Oncol. 2016 May;141(2):231-239. doi: 10.1016/j.ygyno.2015.06.027. Epub 2015 Jun 24.
10
Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients.MGMT、hMLH1、hMSH2 和 BRCA1 蛋白表达对基底样乳腺癌患者新辅助化疗病理完全缓解的预测价值。
Cancer Chemother Pharmacol. 2012 Apr;69(4):923-30. doi: 10.1007/s00280-011-1777-7. Epub 2011 Nov 15.

引用本文的文献

1
Comparison of Post-Operative Complications in Oral Cancer Treated with and without Neoadjuvant Chemotherapy.接受和未接受新辅助化疗的口腔癌术后并发症比较
J Pharm Bioallied Sci. 2023 Jul;15(Suppl 2):S1116-S1118. doi: 10.4103/jpbs.jpbs_196_23. Epub 2023 Jul 11.
2
Effects of relaxation on self-esteem of patients with cancer: a randomized clinical trial.放松对癌症患者自尊的影响:一项随机临床试验。
Support Care Cancer. 2020 Jan;28(1):405-411. doi: 10.1007/s00520-019-05025-3. Epub 2019 Aug 16.

本文引用的文献

1
Acute myeloid leukaemia: challenges and real world data from India.急性髓系白血病:来自印度的挑战与真实世界数据。
Br J Haematol. 2015 Jul;170(1):110-7. doi: 10.1111/bjh.13406. Epub 2015 Apr 9.
2
A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays.一项旨在改善发展中国家儿童急性淋巴细胞白血病治疗相关死亡率和治疗中断情况的策略揭示了治疗延迟的影响。
Pediatr Blood Cancer. 2015 Aug;62(8):1395-402. doi: 10.1002/pbc.25510. Epub 2015 Mar 24.
3
Pilot study of single-day distress screening with the NCCN distress thermometer to evaluate the feasibility of routine distress screening in tertiary cancer center in rural India.
使用美国国立综合癌症网络(NCCN)苦恼温度计进行单日苦恼筛查的试点研究,以评估印度农村地区三级癌症中心进行常规苦恼筛查的可行性。
Psychooncology. 2015 Jul;24(7):832-4. doi: 10.1002/pon.3739. Epub 2014 Dec 22.
4
Cancer care delivery in India at the grassroot level: Improve outcomes.印度基层癌症护理服务:改善治疗效果。
Indian J Med Paediatr Oncol. 2014 Jul;35(3):187-91. doi: 10.4103/0971-5851.142030.
5
Indian Council of Medical Research consensus document for the management of buccal mucosa cancer.印度医学研究理事会关于颊黏膜癌管理的共识文件。
Indian J Med Paediatr Oncol. 2014 Apr;35(2):136-9. doi: 10.4103/0971-5851.138953.
6
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.对于局部进展非常严重、技术上无法切除的口腔癌,先进行新辅助化疗,然后再进行手术。
Oral Oncol. 2014 Oct;50(10):1000-4. doi: 10.1016/j.oraloncology.2014.07.015. Epub 2014 Aug 15.
7
Underutilization of curative treatment among patients with non small cell lung cancer: experience from a tertiary care centre in India.印度一家三级医疗中心的经验:非小细胞肺癌患者的治愈性治疗未得到充分利用。
Asian Pac J Cancer Prev. 2014;15(6):2875-8. doi: 10.7314/apjcp.2014.15.6.2875.
8
Challenges to effective cancer control in China, India, and Russia.中国、印度和俄罗斯有效癌症控制面临的挑战。
Lancet Oncol. 2014 Apr;15(5):489-538. doi: 10.1016/S1470-2045(14)70029-4.
9
Closing the global cancer divide--performance of breast cancer care services in a middle income developing country.缩小全球癌症差距——中等收入发展中国家乳腺癌护理服务的表现。
BMC Cancer. 2014 Mar 20;14:212. doi: 10.1186/1471-2407-14-212.
10
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.一项比较诱导化疗后放化疗与单纯放化疗作为不可切除头颈部癌症治疗的随机 III 期试验。
Ann Oncol. 2014 Jan;25(1):216-25. doi: 10.1093/annonc/mdt461. Epub 2013 Nov 19.